APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Topical Pain Relief

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-opioid Topical Pain Relief Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchNon-opioid Topical Pain Relief Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Topical Pain Relief Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Non-opioid Topical Pain Relief Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Topical Pain Relief Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Topical Pain Relief Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Non-opioid Topical Pain Relief market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-opioid Topical Pain Relief market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-opioid Topical Pain Relief market include Teva Pharmaceutical, Sanofi, Johnson and Johnson, Mylan, Pfizer, GlaxoSmithKline, Topical BioMedics, Tibet Cheezheng Tibetan Medicine and Sun Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-opioid Topical Pain Relief market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-opioid Topical Pain Relief and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-opioid Topical Pain Relief sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-opioid Topical Pain Relief market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-opioid Topical Pain Relief Segment by Company

Teva Pharmaceutical

Sanofi

Johnson and Johnson

Mylan

Pfizer

GlaxoSmithKline

Topical BioMedics

Tibet Cheezheng Tibetan Medicine

Sun Pharmaceutical Industries

Reckitt Benckiser Group

Lingrui Pharmaceutical

Hisamitsu

China Resources Sanjiu Medical & Pharmaceutical

AdvaCare Pharma

Abacus Health Products

Non-opioid Topical Pain Relief Segment by Type

Prescription Pain Relief

Over-The-Counter Pain Relief

Non-opioid Topical Pain Relief Segment by Application

Clinic

Hospital

Pharmacy

Others

Non-opioid Topical Pain Relief Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-opioid Topical Pain Relief status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-opioid Topical Pain Relief market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-opioid Topical Pain Relief significant trends, drivers, influence factors in global and regions.

6. To analyze Non-opioid Topical Pain Relief competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Topical Pain Relief market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Topical Pain Relief and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Topical Pain Relief.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-opioid Topical Pain Relief market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-opioid Topical Pain Relief industry.

Chapter 3: Detailed analysis of Non-opioid Topical Pain Relief manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-opioid Topical Pain Relief in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-opioid Topical Pain Relief in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-opioid Topical Pain Relief Industry Trends Table 2. Non-opioid Topical Pain Relief Industry Drivers Table 3. Non-opioid Topical Pain Relief Industry Opportunities and Challenges Table 4. Non-opioid Topical Pain Relief Industry Restraints Table 5. Global Non-opioid Topical Pain Relief Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-opioid Topical Pain Relief Revenue Share by Company (2021-2026) Table 7. Global Non-opioid Topical Pain Relief Sales Volume by Company (k units) & (2021-2026) Table 8. Global Non-opioid Topical Pain Relief Sales Volume Share by Company (2021-2026) Table 9. Global Non-opioid Topical Pain Relief Average Price (US$/unit) of Company (2021-2026) Table 10. Global Non-opioid Topical Pain Relief Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-opioid Topical Pain Relief Key Company Manufacturing Base & Headquarters Table 12. Global Non-opioid Topical Pain Relief Company, Product Type & Application Table 13. Global Non-opioid Topical Pain Relief Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-opioid Topical Pain Relief by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Prescription Pain Relief Table 18. Significant Companies of Over-The-Counter Pain Relief Table 19. Global Non-opioid Topical Pain Relief Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Non-opioid Topical Pain Relief Sales Volume by Type (2021-2026) & (k units) Table 21. Global Non-opioid Topical Pain Relief Sales Volume by Type (2027-2032) & (k units) Table 22. Global Non-opioid Topical Pain Relief Sales Volume Share by Type (2021-2026) Table 23. Global Non-opioid Topical Pain Relief Sales Volume Share by Type (2027-2032) Table 24. Global Non-opioid Topical Pain Relief Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Non-opioid Topical Pain Relief Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Non-opioid Topical Pain Relief Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Non-opioid Topical Pain Relief Sales Value Share by Type (2021-2026) Table 28. Global Non-opioid Topical Pain Relief Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Others Table 33. Global Non-opioid Topical Pain Relief Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Non-opioid Topical Pain Relief Sales Volume by Application (2021-2026) & (k units) Table 35. Global Non-opioid Topical Pain Relief Sales Volume by Application (2027-2032) & (k units) Table 36. Global Non-opioid Topical Pain Relief Sales Volume Share by Application (2021-2026) Table 37. Global Non-opioid Topical Pain Relief Sales Volume Share by Application (2027-2032) Table 38. Global Non-opioid Topical Pain Relief Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Non-opioid Topical Pain Relief Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Non-opioid Topical Pain Relief Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Non-opioid Topical Pain Relief Sales Value Share by Application (2021-2026) Table 42. Global Non-opioid Topical Pain Relief Sales Value Share by Application (2027-2032) Table 43. Global Non-opioid Topical Pain Relief Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Non-opioid Topical Pain Relief Sales by Region (2021-2026) & (k units) Table 45. Global Non-opioid Topical Pain Relief Sales Market Share by Region (2021-2026) Table 46. Global Non-opioid Topical Pain Relief Sales by Region (2027-2032) & (k units) Table 47. Global Non-opioid Topical Pain Relief Sales Market Share by Region (2027-2032) Table 48. Global Non-opioid Topical Pain Relief Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Non-opioid Topical Pain Relief Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Non-opioid Topical Pain Relief Sales Value Share by Region (2021-2026) Table 51. Global Non-opioid Topical Pain Relief Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Non-opioid Topical Pain Relief Sales Value Share by Region (2027-2032) Table 53. Global Non-opioid Topical Pain Relief Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Non-opioid Topical Pain Relief Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Non-opioid Topical Pain Relief Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Non-opioid Topical Pain Relief Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 58. Global Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2026) Table 59. Global Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 60. Global Non-opioid Topical Pain Relief Sales Market Share by Country (2027-2032) Table 61. Global Non-opioid Topical Pain Relief Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Non-opioid Topical Pain Relief Sales Value Market Share by Country (2021-2026) Table 63. Global Non-opioid Topical Pain Relief Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Non-opioid Topical Pain Relief Sales Value Market Share by Country (2027-2032) Table 65. Teva Pharmaceutical Company Information Table 66. Teva Pharmaceutical Business Overview Table 67. Teva Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 69. Teva Pharmaceutical Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Sanofi Non-opioid Topical Pain Relief Product Portfolio Table 74. Sanofi Recent Development Table 75. Johnson and Johnson Company Information Table 76. Johnson and Johnson Business Overview Table 77. Johnson and Johnson Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio Table 79. Johnson and Johnson Recent Development Table 80. Mylan Company Information Table 81. Mylan Business Overview Table 82. Mylan Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Mylan Non-opioid Topical Pain Relief Product Portfolio Table 84. Mylan Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Pfizer Non-opioid Topical Pain Relief Product Portfolio Table 89. Pfizer Recent Development Table 90. GlaxoSmithKline Company Information Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio Table 94. GlaxoSmithKline Recent Development Table 95. Topical BioMedics Company Information Table 96. Topical BioMedics Business Overview Table 97. Topical BioMedics Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio Table 99. Topical BioMedics Recent Development Table 100. Tibet Cheezheng Tibetan Medicine Company Information Table 101. Tibet Cheezheng Tibetan Medicine Business Overview Table 102. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio Table 104. Tibet Cheezheng Tibetan Medicine Recent Development Table 105. Sun Pharmaceutical Industries Company Information Table 106. Sun Pharmaceutical Industries Business Overview Table 107. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio Table 109. Sun Pharmaceutical Industries Recent Development Table 110. Reckitt Benckiser Group Company Information Table 111. Reckitt Benckiser Group Business Overview Table 112. Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio Table 114. Reckitt Benckiser Group Recent Development Table 115. Lingrui Pharmaceutical Company Information Table 116. Lingrui Pharmaceutical Business Overview Table 117. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 119. Lingrui Pharmaceutical Recent Development Table 120. Hisamitsu Company Information Table 121. Hisamitsu Business Overview Table 122. Hisamitsu Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Hisamitsu Non-opioid Topical Pain Relief Product Portfolio Table 124. Hisamitsu Recent Development Table 125. China Resources Sanjiu Medical & Pharmaceutical Company Information Table 126. China Resources Sanjiu Medical & Pharmaceutical Business Overview Table 127. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 129. China Resources Sanjiu Medical & Pharmaceutical Recent Development Table 130. AdvaCare Pharma Company Information Table 131. AdvaCare Pharma Business Overview Table 132. AdvaCare Pharma Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio Table 134. AdvaCare Pharma Recent Development Table 135. Abacus Health Products Company Information Table 136. Abacus Health Products Business Overview Table 137. Abacus Health Products Non-opioid Topical Pain Relief Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio Table 139. Abacus Health Products Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Non-opioid Topical Pain Relief Distributors List Table 143. Non-opioid Topical Pain Relief Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Non-opioid Topical Pain Relief Product Image Figure 2. Global Non-opioid Topical Pain Relief Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Topical Pain Relief Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-opioid Topical Pain Relief Sales (2021-2032) & (k units) Figure 5. Global Non-opioid Topical Pain Relief Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Non-opioid Topical Pain Relief Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Prescription Pain Relief Image Figure 10. Over-The-Counter Pain Relief Image Figure 11. Global Non-opioid Topical Pain Relief Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Non-opioid Topical Pain Relief Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Non-opioid Topical Pain Relief Sales Volume Share by Type (2021-2032) Figure 14. Global Non-opioid Topical Pain Relief Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Non-opioid Topical Pain Relief Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Non-opioid Topical Pain Relief Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Others Image Figure 21. Global Non-opioid Topical Pain Relief Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Non-opioid Topical Pain Relief Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Non-opioid Topical Pain Relief Sales Volume Share by Application (2021-2032) Figure 24. Global Non-opioid Topical Pain Relief Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Non-opioid Topical Pain Relief Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Non-opioid Topical Pain Relief Sales Value Share by Application (2021-2032) Figure 27. Global Non-opioid Topical Pain Relief Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Non-opioid Topical Pain Relief Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Non-opioid Topical Pain Relief Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Non-opioid Topical Pain Relief Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Non-opioid Topical Pain Relief Sales Value (2021-2032) & (US$ Million) Figure 32. North America Non-opioid Topical Pain Relief Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Non-opioid Topical Pain Relief Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Non-opioid Topical Pain Relief Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Non-opioid Topical Pain Relief Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Non-opioid Topical Pain Relief Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Non-opioid Topical Pain Relief Sales Value (2021-2032) & (US$ Million) Figure 38. South America Non-opioid Topical Pain Relief Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Non-opioid Topical Pain Relief Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Non-opioid Topical Pain Relief Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Non-opioid Topical Pain Relief Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Non-opioid Topical Pain Relief Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Pain Relief
  • Over-The-Counter Pain Relief
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Johnson and Johnson
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • Topical BioMedics
  • Tibet Cheezheng Tibetan Medicine
  • Sun Pharmaceutical Industries
  • Reckitt Benckiser Group
  • Lingrui Pharmaceutical
  • Hisamitsu
  • China Resources Sanjiu Medical & Pharmaceutical
  • AdvaCare Pharma
  • Abacus Health Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-opioid Topical Pain Relief Sales Value (2021-2032)
  4. 1.2.2 Global Non-opioid Topical Pain Relief Sales Volume (2021-2032)
  5. 1.2.3 Global Non-opioid Topical Pain Relief Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-opioid Topical Pain Relief Market Dynamics
  1. 2.1 Non-opioid Topical Pain Relief Industry Trends
  2. 2.2 Non-opioid Topical Pain Relief Industry Drivers
  3. 2.3 Non-opioid Topical Pain Relief Industry Opportunities and Challenges
  4. 2.4 Non-opioid Topical Pain Relief Industry Restraints
3 Non-opioid Topical Pain Relief Market by Company
  1. 3.1 Global Non-opioid Topical Pain Relief Company Revenue Ranking in 2025
  2. 3.2 Global Non-opioid Topical Pain Relief Revenue by Company (2021-2026)
  3. 3.3 Global Non-opioid Topical Pain Relief Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-opioid Topical Pain Relief Average Price by Company (2021-2026)
  5. 3.5 Global Non-opioid Topical Pain Relief Company Ranking (2024-2026)
  6. 3.6 Global Non-opioid Topical Pain Relief Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-opioid Topical Pain Relief Company Product Type and Application
  8. 3.8 Global Non-opioid Topical Pain Relief Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-opioid Topical Pain Relief Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-opioid Topical Pain Relief Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-opioid Topical Pain Relief Market by Type
  1. 4.1 Non-opioid Topical Pain Relief Type Introduction
  2. 4.1.1 Prescription Pain Relief
  3. 4.1.2 Over-The-Counter Pain Relief
  4. 4.2 Global Non-opioid Topical Pain Relief Sales Volume by Type
  5. 4.2.1 Global Non-opioid Topical Pain Relief Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-opioid Topical Pain Relief Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Non-opioid Topical Pain Relief Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Non-opioid Topical Pain Relief Sales Value by Type
  9. 4.3.1 Global Non-opioid Topical Pain Relief Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Non-opioid Topical Pain Relief Sales Value by Type (2021-2032)
  11. 4.3.3 Global Non-opioid Topical Pain Relief Sales Value Share by Type (2021-2032)
5 Non-opioid Topical Pain Relief Market by Application
  1. 5.1 Non-opioid Topical Pain Relief Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Non-opioid Topical Pain Relief Sales Volume by Application
  7. 5.2.1 Global Non-opioid Topical Pain Relief Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Non-opioid Topical Pain Relief Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Non-opioid Topical Pain Relief Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Non-opioid Topical Pain Relief Sales Value by Application
  11. 5.3.1 Global Non-opioid Topical Pain Relief Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Non-opioid Topical Pain Relief Sales Value by Application (2021-2032)
  13. 5.3.3 Global Non-opioid Topical Pain Relief Sales Value Share by Application (2021-2032)
6 Non-opioid Topical Pain Relief Regional Sales and Value Analysis
  1. 6.1 Global Non-opioid Topical Pain Relief Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-opioid Topical Pain Relief Sales by Region (2021-2032)
  3. 6.2.1 Global Non-opioid Topical Pain Relief Sales by Region: 2021-2026
  4. 6.2.2 Global Non-opioid Topical Pain Relief Sales by Region (2027-2032)
  5. 6.3 Global Non-opioid Topical Pain Relief Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-opioid Topical Pain Relief Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-opioid Topical Pain Relief Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-opioid Topical Pain Relief Sales Value by Region (2027-2032)
  9. 6.5 Global Non-opioid Topical Pain Relief Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-opioid Topical Pain Relief Sales Value (2021-2032)
  12. 6.6.2 North America Non-opioid Topical Pain Relief Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-opioid Topical Pain Relief Sales Value (2021-2032)
  15. 6.7.2 Europe Non-opioid Topical Pain Relief Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-opioid Topical Pain Relief Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-opioid Topical Pain Relief Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-opioid Topical Pain Relief Sales Value (2021-2032)
  21. 6.9.2 South America Non-opioid Topical Pain Relief Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-opioid Topical Pain Relief Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-opioid Topical Pain Relief Sales Value Share by Country, 2025 VS 2032
7 Non-opioid Topical Pain Relief Country-level Sales and Value Analysis
  1. 7.1 Global Non-opioid Topical Pain Relief Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-opioid Topical Pain Relief Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-opioid Topical Pain Relief Sales by Country (2021-2032)
  4. 7.3.1 Global Non-opioid Topical Pain Relief Sales by Country (2021-2026)
  5. 7.3.2 Global Non-opioid Topical Pain Relief Sales by Country (2027-2032)
  6. 7.4 Global Non-opioid Topical Pain Relief Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-opioid Topical Pain Relief Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-opioid Topical Pain Relief Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-opioid Topical Pain Relief Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-opioid Topical Pain Relief Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-opioid Topical Pain Relief Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Non-opioid Topical Pain Relief Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson and Johnson
  14. 8.3.1 Johnson and Johnson Company Information
  15. 8.3.2 Johnson and Johnson Business Overview
  16. 8.3.3 Johnson and Johnson Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio
  18. 8.3.5 Johnson and Johnson Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Non-opioid Topical Pain Relief Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Non-opioid Topical Pain Relief Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Topical BioMedics
  38. 8.7.1 Topical BioMedics Company Information
  39. 8.7.2 Topical BioMedics Business Overview
  40. 8.7.3 Topical BioMedics Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio
  42. 8.7.5 Topical BioMedics Recent Developments
  43. 8.8 Tibet Cheezheng Tibetan Medicine
  44. 8.8.1 Tibet Cheezheng Tibetan Medicine Company Information
  45. 8.8.2 Tibet Cheezheng Tibetan Medicine Business Overview
  46. 8.8.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio
  48. 8.8.5 Tibet Cheezheng Tibetan Medicine Recent Developments
  49. 8.9 Sun Pharmaceutical Industries
  50. 8.9.1 Sun Pharmaceutical Industries Company Information
  51. 8.9.2 Sun Pharmaceutical Industries Business Overview
  52. 8.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio
  54. 8.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 8.10 Reckitt Benckiser Group
  56. 8.10.1 Reckitt Benckiser Group Company Information
  57. 8.10.2 Reckitt Benckiser Group Business Overview
  58. 8.10.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio
  60. 8.10.5 Reckitt Benckiser Group Recent Developments
  61. 8.11 Lingrui Pharmaceutical
  62. 8.11.1 Lingrui Pharmaceutical Company Information
  63. 8.11.2 Lingrui Pharmaceutical Business Overview
  64. 8.11.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  66. 8.11.5 Lingrui Pharmaceutical Recent Developments
  67. 8.12 Hisamitsu
  68. 8.12.1 Hisamitsu Company Information
  69. 8.12.2 Hisamitsu Business Overview
  70. 8.12.3 Hisamitsu Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hisamitsu Non-opioid Topical Pain Relief Product Portfolio
  72. 8.12.5 Hisamitsu Recent Developments
  73. 8.13 China Resources Sanjiu Medical & Pharmaceutical
  74. 8.13.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
  75. 8.13.2 China Resources Sanjiu Medical & Pharmaceutical Business Overview
  76. 8.13.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  78. 8.13.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments
  79. 8.14 AdvaCare Pharma
  80. 8.14.1 AdvaCare Pharma Company Information
  81. 8.14.2 AdvaCare Pharma Business Overview
  82. 8.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio
  84. 8.14.5 AdvaCare Pharma Recent Developments
  85. 8.15 Abacus Health Products
  86. 8.15.1 Abacus Health Products Company Information
  87. 8.15.2 Abacus Health Products Business Overview
  88. 8.15.3 Abacus Health Products Non-opioid Topical Pain Relief Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio
  90. 8.15.5 Abacus Health Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-opioid Topical Pain Relief Value Chain Analysis
  2. 9.1.1 Non-opioid Topical Pain Relief Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-opioid Topical Pain Relief Sales Mode & Process
  6. 9.2 Non-opioid Topical Pain Relief Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-opioid Topical Pain Relief Distributors
  9. 9.2.3 Non-opioid Topical Pain Relief Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst